ARK Innovation ETF (ARKK)

43.19
Delayed Data
As of May 25
 -0.06 / -0.14%
Today’s Change
27.70
Today|||52-Week Range
45.35
+16.48%
Year-to-Date

Investment Objective

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The advisor currently intends to use only American Depositary Receipts ("ADRs") when purchasing foreign securities. The fund is non-diversified.

Winners of Q1 Earnings: 5 Best ETF Charts
May 24 / Zacks.com - Paid Partner Content
 

Performance

1 month+11.04% 3 years+27.75%
3 months+4.15% 5 years--
1 year+53.07% Since inception+25.27%
Data through 05/26/2018

Quote Details

Previous close$43.25
Open day’s range43.09 – 43.41
Net asset value (NAV)43.14 (05/25/2018)
Daily volume183,974
Average volume (3 months)358,778
Data as of 8:00pm ET, 05/25/2018

Peer Comparisonvs. Technology ETFs

 ARKKCategory
Performance 5-yr return--+19.08%
Expense Gross exp ratio0.75%1.36%
Risk 5 year sharpe ratio--1.28
Net assets$709.4M$1.3B
Average market cap$8.9B$52.5B
Average P/E--25.2
Dividend / Share--0.13%

Competitors

XNTK SPDR® NYSE Technology ETF
IGM iShares North American Tech ETF
RYT PowerShares S&P 500® Equal Weight Techn...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
TSLA Tesla7.68%
SSYS Stratasys Ltd6.72%
NTLA Intellia Therapeutics Inc6.25%
TWTR Twitter4.88%
ILMN Illumina Inc4.54%
BIDU Baidu3.65%
EDIT Editas Medicine Inc3.54%
ATHN athenahealth Inc3.05%
NVTA Invitae Corp3.01%
AMZN Amazon2.95%